Skip to search formSkip to main contentSkip to account menu

Zomepirac sodium

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1993
Highly Cited
1993
OBJECTIVE To examine changes in the prescribing of analgesics after the market entry and subsequent withdrawal of zomepirac… 
Highly Cited
1987
Highly Cited
1987
A large, computerized database derived from Medicaid claims was used to evaluate the risk of allergy and/or anaphylaxis… 
1986
1986
Zomepirac sodium (ZS) (5 mg/kg i.v.) was used to evaluate the effects of preischemia cyclooxygenase inhibition on CBF (as… 
Highly Cited
1984
Highly Cited
1984
  • S. Cooper
  • The American journal of medicine
  • 1984
  • Corpus ID: 24967167
Review
1984
Review
1984
Highly Cited
1984
Highly Cited
1984
The nonsteroidal anti-inflammatory drugs are widely used in the United States and are a frequent cause of cutaneous reactions… 
1983
1983
Our purpose was to compare the analgesic efficacy of single oral doses of ibuprofen, zomepirac, aspirin, and placebo in severe… 
1982
1982
Abstract: Five healthy male human subjects were administered 200 mg oral solution doses of zomepirac‐14C sodium. Plasma and urine… 
1981
1981
Abstract: In a single‐dose, double‐blind crossover study in 40 patients with chronic pain due to advanced cancer, zomepirac… 
1980
1980
Zomepirac sodium (ZS) is an orally active, nonnarcotic, analgesic agent. The disposition and pharmacokinetics of zomepirac (Z…